Catalyst
Slingshot members are tracking this event:
Phase 3 study of Zalviso in patients with post-operative pain expected to complete August 2017
- Source Link:
- https://clinicaltrials.gov/ct2/show/NCT02662764
Do you think this event is important to the companies below? How will it affect their stock price?
Related Companies | Importance
|
Impact on Stocks
|
||||
---|---|---|---|---|---|---|
ACRX |
|
|
Slingshot Insights Explained
Catalyst Date
Occurred on:
Aug 07, 2017
Occurred Source:
https://clinicaltrials.gov/archive/NCT02662764/2017_08_07/changes
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Zalviso, St-operative Pain